The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel humanized antibody targeting CD39 that enhances anti-tumor immunity and the efficacy of cancer immunotherapy.
 
Haruka Ban
Employment - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)
 
Toshifumi Obonai
Employment - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)
 
Yuji Mishima
Employment - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)
 
Noriko Matsumoto
Employment - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)
 
Motoya Mie
Employment - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)
 
Norihiro Nakamura
Leadership - BrightPath Biotheraputics
Research Funding - BrightPath Biotheraputics (Inst)
Patents, Royalties, Other Intellectual Property - BrightPath Biotheraputics (Inst)